Avanza Fonder Ab 10x Genomics, Inc. Transaction History
Avanza Fonder Ab
- $3.05 Trillion
- Q1 2025
A detailed history of Avanza Fonder Ab transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Avanza Fonder Ab holds 63,404 shares of TXG stock, worth $476,164. This represents 0.02% of its overall portfolio holdings.
Number of Shares
63,404
Previous 65,816
3.66%
Holding current value
$476,164
Previous $945 Million
40.63%
% of portfolio
0.02%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding TXG
# of Institutions
310Shares Held
96.2MCall Options Held
76.4KPut Options Held
132K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.9MShares$89.7 Million1.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$82.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$48 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.5.71MShares$42.9 Million0.06% of portfolio
-
Nikko Asset Management Americas, Inc.5.71MShares$42.9 Million0.92% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $714M
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...